50mg retatrutide Rt vial Retatrutide 50mg

Not available in all 50 US states

While GLP-1 drugs have existed since the early 2000s, semaglutide revealed their potential beyond diabetes, particularly in obesity, where past treatments were often found inadequate

Conclusion GLP-1 injections are a proven option for supporting metabolic health under the guidance of a licensed provider

Jumping straight to a higher dose will make you much more likely to experience severe nausea and vomiting

The combination with Wegovy does not increase this risk directly, but any medication affecting fluid balance or renal function requires careful consideration

Most users report no side effects